Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
Peter A. Cassileth(City Of Hope National Medical Center), Peter H. Wiernik(Albert Einstein College of Medicine), Cheryl L. Willman(Mayo Clinic), John M. Bennett(University of Rochester Medical Center), Elisabeth Paietta(Montefiore Medical Center), Jacob M. Rowe(City Of Hope National Medical Center), David R. Head(University of Southern California), David P. Harrington(MACOM (United States)), Karl G. Blume(City Of Hope National Medical Center), Hillard M. Lazarus(University Hospitals of Cleveland), David D. Hurd(Duke University), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 610
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k